These studies generally depicted GLO1 as an amplified and/or overexpressed oncogene and as a bad prognosis marker in different types of malignant tumors (Zhang et al., 2014; Cheng, 2012; Hosoda et al., 2015; Antognelli et al., 2013; Fonseca-Sánchez et al., 2012). Here, GLO1 is linked to cancer.